BU
AVNS icon

BBVA USA’s Avanos Medical AVNS Stock Holding History

BBVA USA’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$0 Hold
11
– – ﹤0.01% 976
2021
Q2 		$0 Buy
+11
New +$455 ﹤0.01% 1005

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BBVA USA's AVNS Position: Q3 2021 in Review

BBVA USA held its Avanos Medical (AVNS) position steady in Q3 2021 at 11 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #976.

BBVA USA first reported a position in AVNS in Q2 2021 and has held it in 2 quarters since. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2021.

  • BBVA USA held 11 shares of Avanos Medical worth $0 as of Q3 2021.
  • BBVA USA left its Avanos Medical share count unchanged in Q3 2021.
  • Avanos Medical made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #976 holding.
  • BBVA USA first reported a position in Avanos Medical in Q2 2021 and has held it in 2 quarters since.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.